Acetaminophen

Generic Name
Acetaminophen
Brand Names
Acephen, Acetadryl, Allzital, Apadaz, Arthriten Inflammatory Pain, Bupap, Butapap, Cetafen, Children's Silapap, Coricidin Hbp Cold & Flu, Darvocet-N, Dayquil Sinex, Diphen, Dolofin, Dologen, Dologesic Reformulated Jun 2016, Duralgina, Dvorah, Endocet, Esgic, Exaprin, Excedrin, Excedrin PM Triple Action, Excedrin Tension Headache, Feverall, Fioricet, Fioricet With Codeine, Goody's Back & Body Pain Relief, Goody's Body Pain, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Hycet, Legatrin PM, Little Fevers, Lorcet, Lortab, Mapap, Mersyndol, Midol Complete, Midol Cramps & Bodyaches, Nalocet, Norco, Orbivan, Pamprin Max Formula, Pamprin Multi-symptom, Panadol, Pediacare Children's Fever Reducer Pain Reliever, Percocet, Percogesic Reformulated Jan 2011, Pharbetol, Premsyn Pms, Prolate, Rivacocet, Robaxacet, Robaxacet-8, Roxicet, Sudafed PE Sinus Headache, Tactinal, Tencon, Trezix, Triatec, Triatec-30, Triatec-8, Tylenol, Tylenol PM, Tylenol With Codeine, Ultracet, Vanatol, Vanatol S, Vanquish, Xodol, Xolox, Zamicet, Zflex, Zydone
Drug Type
Small Molecule
Chemical Formula
C8H9NO2
CAS Number
103-90-2
Unique Ingredient Identifier
362O9ITL9D
Background

Acetaminophen (paracetamol), also commonly known as Tylenol, is the most commonly taken analgesic worldwide and is recommended as first-line therapy in pain conditions by the World Health Organization (WHO). It is also used for its antipyretic effects, helping to reduce fever. This drug was initially approved by the U.S. FDA in 1951 and is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms.

Acetaminophen is often found combined with other drugs in more than 600 over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Confusion about dosing of this drug may be caused by the availability of different formulas, strengths, and dosage instructions for children of different ages. Due to the possibility of fatal overdose and liver failure associated with the incorrect use of acetaminophen, it is important to follow current and available national and manufacturer dosing guidelines while this drug is taken or prescribed.

Indication

In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms.

Acetaminophen injection is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.

Associated Conditions
Acute Gouty Arthritis, Acute Musculoskeletal Pain, Allergic Reaction, Allergy to Tree Pollen, Ankylosing Spondylitis (AS), Chills, Cold, Common Cold, Cough, Cough caused by Common Cold, Coughing caused by Flu caused by Influenza, Dyskinesia of the Biliary Tract, Dyskinesia of the Urinary Tract, Febrile Convulsions, Febrile Illness Acute, Fever, Fibromyalgia, Flu caused by Influenza, Headache, Joint dislocations, Menstrual Distress (Dysmenorrhea), Mild pain, Muscle Inflammation, Muscle Injuries, Muscle Spasms, Musculoskeletal Pain, Myalgia, Nasal Congestion, Neuropathic Pain, Osteoarthritis (OA), Pain, Postoperative pain, Premenstrual cramps, Rheumatoid Arthritis, Rhinopharyngitis, Rhinorrhoea, Severe Pain, Sinusitis, Spasms, Spastic Pain of the Gastrointestinal Tract, Sprains, Symptoms Cold, Tension Headache, Toothache, Upper Respiratory Tract Infection, Whiplash Syndrome, Acute Torticollis, Articular inflammation, Cold or flu syndrome, Mild to moderate pain, Minor aches and pains, Minor pain, Moderate Pain, Moderate to severe pain
Associated Therapies
Airway secretion clearance therapy, Anti-spasmodics, Bronchodilation

The Paracetamol AfteR Traumatic Brain InjurY Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-11-01
Last Posted Date
2014-10-28
Lead Sponsor
Dr. M.K. Saxena
Target Recruit Count
41
Registration Number
NCT01231139
Locations
🇦🇺

Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia

🇦🇺

St George Hospital, Sydney, New South Wales, Australia

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-10-07
Last Posted Date
2012-08-20
Lead Sponsor
Pfizer
Target Recruit Count
218
Registration Number
NCT01216163
Locations
🇺🇸

Pfizer Investigational Site, Salt Lake City, Utah, United States

Mechanisms of N-acetylcysteine Mediated Vascular Adverse Effects

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-09-27
Last Posted Date
2024-06-20
Lead Sponsor
University of Edinburgh
Target Recruit Count
24
Registration Number
NCT01209455
Locations
🇬🇧

Clinical Research Facility, Royal Infirmary of Edinburgh, Edinburgh, Midlothian, United Kingdom

Paracetamol Toxicity in Septic Patients

Phase 3
Suspended
Conditions
Interventions
First Posted Date
2010-08-17
Last Posted Date
2011-03-02
Lead Sponsor
Barzilai Medical Center
Target Recruit Count
80
Registration Number
NCT01182974
Locations
🇮🇱

Barzilai medical center, Ashkelon, Israel

Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2010-05-11
Last Posted Date
2015-12-07
Lead Sponsor
Vanderbilt University
Registration Number
NCT01120769
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Paracetamol and Glutathion

Phase 1
Completed
Conditions
First Posted Date
2010-05-05
Last Posted Date
2010-05-05
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
18
Registration Number
NCT01116596
Locations
🇫🇷

CHU Clermont-Ferrand, Clermont-Ferrand, France

To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-05-04
Last Posted Date
2012-05-28
Lead Sponsor
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Target Recruit Count
540
Registration Number
NCT01115673
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-04-19
Last Posted Date
2017-06-21
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
31
Registration Number
NCT01105936
Locations
🇪🇸

Hospital Del Mar, Barcelona, Spain

Drug Interaction Between Paracetamol and Warfarin

First Posted Date
2010-04-15
Last Posted Date
2010-04-15
Lead Sponsor
Hopital Lariboisière
Target Recruit Count
45
Registration Number
NCT01104337
Locations
🇫🇷

Therapeutic Research Unit, Department of Internal Medicine, Hospital Lariboière, Paris, France

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

First Posted Date
2010-03-15
Last Posted Date
2023-02-21
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
57
Registration Number
NCT01086540
Locations
🇺🇸

University of Colorado Health Sciences Center, Aurora, Colorado, United States

🇺🇸

University of Minnesota Health Clinics and Surgery Center, Minneapolis, Minnesota, United States

🇺🇸

Boston University Medical Center, Boston, Massachusetts, United States

and more 14 locations
© Copyright 2024. All Rights Reserved by MedPath